<DOC>
<DOCNO>
EP-0005006
</DOCNO>
<TEXT>
<DATE>
19791031
</DATE>
<IPC-CLASSIFICATIONS>
<main>C07D-309/10</main> A61K-31/35 C07D-309/10 C07D-309/00 
</IPC-CLASSIFICATIONS>
<TITLE>
antibacterial monic acid c derivatives, processes for their preparation and compositions containing them.
</TITLE>
<APPLICANT>
beecham group ltdgb  <sep>beecham group limited<sep>beecham group plcbeecham house, great west roadbrentford, middlesex tw8 9bdgb<sep>beecham group plc<sep>
</APPLICANT>
<INVENTOR>
o'hanlon peter john<sep>rogers norman harold<sep>o'hanlon, peter john<sep>rogers, norman harold<sep>o'hanlon, peter john65 green laneredhill surreygb<sep>rogers, norman harold6 the martsrudgwick sussexgb<sep>o'hanlon, peter john <sep>rogers, norman harold<sep>o'hanlon, peter john 65 green lane redhill surrey gb<sep>rogers, norman harold6 the martsrudgwick sussexgb<sep>
</INVENTOR>
<ABSTRACT>
monic acid c and its salts and esters of formula (ii):    where r is a salt-forming ion or pharmaceutically acceptably  ester-forming radical may be prepared by either converting  the epoxide in the known monic acid a to an olefin, or by  hydrolysis of the naturally occurring pseudomonic acid c.   the esters of monic acid c have antibacterial and antimycoplasma  activity and are therefore useful in the treatment  of human and veterinary bacterial and mycoplasma-induced  infections.  
</ABSTRACT>
</TEXT>
</DOC>
